Cancer BiologybioRxivPreprint
Selective inhibition of interleukin-2 inducible T cell kinase (ITK) enhances anti-tumor immunity in association with Th1-skewing, cytotoxic T cell activation, and reduced T cell exhaustion
DOI 10.1101/2023.07.05.547822
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
1 paper
Recent·Most cited